Year: 2025
Type: article
Abstract: NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.
Source: Psychopharmacology Bulletin
DOI: 10.64719/pb.4496
Authors: Ahmed Naguy, Bibi Alamiri
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4400599688